These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 33335946)
1. CRISPR/Cas9-mediated generation and analysis of N terminus polymorphic models of β Kondrashov A; Mohd Yusof NAN; Hasan A; Goulding J; Kodagoda T; Hoang DM; Vo NTN; Melarangi T; Dolatshad N; Gorelik J; Hill SJ; Harding SE; Denning C Mol Ther Methods Clin Dev; 2021 Mar; 20():39-53. PubMed ID: 33335946 [TBL] [Abstract][Full Text] [Related]
2. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773 [TBL] [Abstract][Full Text] [Related]
3. Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi. Melsom CB; Hussain RI; Ørstavik Ø; Aronsen JM; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Krobert KA Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1177-86. PubMed ID: 25216690 [TBL] [Abstract][Full Text] [Related]
4. Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells. Kondrashov A; Duc Hoang M; Smith JGW; Bhagwan JR; Duncan G; Mosqueira D; Munoz MB; Vo NTN; Denning C Stem Cells Dev; 2018 Mar; 27(6):391-404. PubMed ID: 29402189 [TBL] [Abstract][Full Text] [Related]
5. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells. Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921 [TBL] [Abstract][Full Text] [Related]
6. The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Xiang Y; Kobilka B Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10776-81. PubMed ID: 12954981 [TBL] [Abstract][Full Text] [Related]
7. Purinergic Receptor Transactivation by the Stallaert W; van der Westhuizen ET; Schönegge AM; Plouffe B; Hogue M; Lukashova V; Inoue A; Ishida S; Aoki J; Le Gouill C; Bouvier M Mol Pharmacol; 2017 May; 91(5):533-544. PubMed ID: 28280061 [TBL] [Abstract][Full Text] [Related]
8. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor. Tepe NM; Liggett SB J Recept Signal Transduct Res; 2000 Jan; 20(1):75-85. PubMed ID: 10711498 [TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated genome editing in human stem cell-derived cardiomyocytes: Applications for cardiovascular disease modelling and cardiotoxicity screening. Christidi E; Huang HM; Brunham LR Drug Discov Today Technol; 2018 Aug; 28():13-21. PubMed ID: 30205876 [TBL] [Abstract][Full Text] [Related]
10. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. Seifert R; Wenzel-Seifert K; Lee TW; Gether U; Sanders-Bush E; Kobilka BK J Biol Chem; 1998 Feb; 273(9):5109-16. PubMed ID: 9478963 [TBL] [Abstract][Full Text] [Related]
11. Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced Cardiotoxicity. Maillet A; Tan KP; Brunham LR Curr Protoc Toxicol; 2017 Aug; 73():22.5.1-22.5.22. PubMed ID: 28777443 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling. Mutlu GM; Dumasius V; Burhop J; McShane PJ; Meng FJ; Welch L; Dumasius A; Mohebahmadi N; Thakuria G; Hardiman K; Matalon S; Hollenberg S; Factor P Circ Res; 2004 Apr; 94(8):1091-100. PubMed ID: 15016730 [TBL] [Abstract][Full Text] [Related]
13. T-tubule remodelling disturbs localized β2-adrenergic signalling in rat ventricular myocytes during the progression of heart failure. Schobesberger S; Wright P; Tokar S; Bhargava A; Mansfield C; Glukhov AV; Poulet C; Buzuk A; Monszpart A; Sikkel M; Harding SE; Nikolaev VO; Lyon AR; Gorelik J Cardiovasc Res; 2017 Jun; 113(7):770-782. PubMed ID: 28505272 [TBL] [Abstract][Full Text] [Related]
14. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653 [TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Mosqueira D; Mannhardt I; Bhagwan JR; Lis-Slimak K; Katili P; Scott E; Hassan M; Prondzynski M; Harmer SC; Tinker A; Smith JGW; Carrier L; Williams PM; Gaffney D; Eschenhagen T; Hansen A; Denning C Eur Heart J; 2018 Nov; 39(43):3879-3892. PubMed ID: 29741611 [TBL] [Abstract][Full Text] [Related]
16. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Wenzel-Seifert K; Liu HY; Seifert R Biochem Pharmacol; 2002 Jul; 64(1):9-20. PubMed ID: 12106601 [TBL] [Abstract][Full Text] [Related]